Patterns of failure in patients with head and neck carcinoma of unknown primary treated with radiation therapy

被引:19
作者
Cuaron, John [1 ]
Rao, Shyam [1 ]
Wolden, Suzanne [1 ]
Zelefsky, Michael [1 ]
Schupak, Karen [1 ]
Mychalczak, Borys [1 ]
Lee, Nancy [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, 1275 York Ave, New York, NY 10065 USA
来源
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK | 2016年 / 38卷
关键词
unknown primary; head and neck; radiation therapy; LYMPH-NODE METASTASES; SQUAMOUS-CELL CARCINOMA; INTENSITY-MODULATED RADIOTHERAPY; PRIMARY SITE; HUMAN-PAPILLOMAVIRUS; PRIMARY-CANCER; PRIMARY TUMOR; MANAGEMENT; OUTCOMES; RELAPSE;
D O I
10.1002/hed.24013
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Background. The purpose of this study was to examine patterns of failure and the relationship to radiation doses in patients with head and neck carcinoma of unknown primary (HNCUP). Methods. We reviewed 85 patients with HNCUP treated with curativeintent radiation therapy (RT) during 1995 to 2012. Results. There have been no failures in the pharyngeal axis. Relapse at initial neck sites of disease developed in 7 patients (8.2%). The median dose to these sites was 70 Gy (range, 63-70 Gy). Failure at neck sites without initial disease occurred in 4 patients (4.7%). The median dose was 54 Gy (range, 50-58.8 Gy). There were no contralateral failures in a small cohort of patients receiving unilateral treatment (n = 6). Percutaneous endoscopic gastrostomy (PEG) tube dependence at 12 months was 7.4%, and 2.5% at 3 years. Esophageal stricture developed in 5 patients (5.9%). Conclusion. RT for HNCUP produces excellent locoregional control rates with acceptably low levels of late toxicity. Doses prescribed to sites of eventual failure did not vary significantly from those sites that were treated and remain in control. (C) 2015 Wiley Periodicals, Inc.
引用
收藏
页码:E426 / E431
页数:6
相关论文
共 33 条
[1]  
[Anonymous], 2014, COCHRANE DATABASE SY
[2]   Larynx-sparing radiotherapy for squamous cell carcinoma from an unknown head and neck primary site [J].
Barker, CA ;
Morris, CG ;
Mendenhall, WM .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2005, 28 (05) :445-448
[3]   Role of radiotherapy in the treatment of cervical lymph node metastases from an unknown primary site: Retrospective analysis of 113 patients [J].
Beldi, Debora ;
Jereczek-Fossa, Barbara A. ;
D'Onofrio, Alberto ;
Gambaro, Giuseppina ;
Fiore, Maria Rosaria ;
Pia, Francesco ;
Chiesa, Fausto ;
Orecchia, Roberto ;
Krengli, Marco .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (04) :1051-1058
[4]   Salivary gland-sparing other than parotid-sparing in definitive head-and-neck intensity-modulated radiotherapy does not seem to jeopardize local control [J].
Chajon, Enrique ;
Lafond, Caroline ;
Louvel, Guillaume ;
Castelli, Joel ;
Williaume, Daniele ;
Henry, Olivier ;
Jegoux, Franck ;
Vauleon, Elodie ;
Manens, Jean-Pierre ;
Le Prise, Elisabeth ;
de Crevoisier, Renaud .
RADIATION ONCOLOGY, 2013, 8
[5]   IMPROVED DOSIMETRIC AND CLINICAL OUTCOMES WITH INTENSITY-MODULATED RADIOTHERAPY FOR HEAD-AND-NECK CANCER OF UNKNOWN PRIMARY ORIGIN [J].
Chen, Allen M. ;
Li, Bao-Qing ;
Farwell, D. Gregory ;
Marsano, Joseph ;
Vijayakumar, Srinivasan ;
Purdy, James A. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 79 (03) :756-762
[6]   METASTASES TO LYMPH-NODES OF HEAD AND NECK FROM AN UNKNOWN PRIMARY SITE [J].
COKER, DD ;
CASTERLINE, PF ;
CHAMBERS, RG ;
JAQUES, DA .
AMERICAN JOURNAL OF SURGERY, 1977, 134 (04) :517-522
[7]   Submandibular gland-sparing intensity modulated radiotherapy in the treatment of head and neck cancer: Sites of locoregional relapse and survival [J].
Collan, Juhani ;
Kapanen, Mika ;
Makitie, Antti ;
Nyman, Heidi ;
Joensuu, Heikki ;
Tenhunen, Mikko ;
Saarilahti, Kauko .
ACTA ONCOLOGICA, 2012, 51 (06) :735-742
[8]  
Colletier PJ, 1998, HEAD NECK-J SCI SPEC, V20, P674, DOI 10.1002/(SICI)1097-0347(199812)20:8<674::AID-HED3>3.0.CO
[9]  
2-H
[10]   CERVICAL NODAL METASTASIS OF SQUAMOUS-CELL CARCINOMA OF UNKNOWN ORIGIN - INDICATIONS FOR WITHHOLDING RADIATION-THERAPY [J].
COSTER, JR ;
FOOTE, RL ;
OLSEN, KD ;
JACK, SM ;
SCHAID, DJ ;
DESANTO, LW .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1992, 23 (04) :743-749